CADASIL Affects Multiple Aspects of Cerebral Small Vessel Function on 7T-MRI.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
01 2023
Historique:
revised: 05 10 2022
received: 12 05 2022
accepted: 07 10 2022
pubmed: 13 10 2022
medline: 12 1 2023
entrez: 12 10 2022
Statut: ppublish

Résumé

Cerebral small vessel diseases (cSVDs) are a major cause of stroke and dementia. We used cutting-edge 7T-MRI techniques in patients with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), to establish which aspects of cerebral small vessel function are affected by this monogenic form of cSVD. We recruited 23 CADASIL patients (age 51.1 ± 10.1 years, 52% women) and 13 age- and sex-matched controls (46.1 ± 12.6, 46% women). Small vessel function measures included: basal ganglia and centrum semiovale perforating artery blood flow velocity and pulsatility, vascular reactivity to a visual stimulus in the occipital cortex and reactivity to hypercapnia in the cortex, subcortical gray matter, white matter, and white matter hyperintensities. Compared with controls, CADASIL patients showed lower blood flow velocity and higher pulsatility index within perforating arteries of the centrum semiovale (mean difference - 0.09 cm/s, p = 0.03 and 0.20, p = 0.009) and basal ganglia (mean difference - 0.98 cm/s, p = 0.003 and 0.17, p = 0.06). Small vessel reactivity to a short visual stimulus was decreased (blood-oxygen-level dependent [BOLD] mean difference -0.21%, p = 0.04) in patients, while reactivity to hypercapnia was preserved in the cortex, subcortical gray matter, and normal appearing white matter. Among patients, reactivity to hypercapnia was decreased in white matter hyperintensities compared to normal appearing white matter (BOLD mean difference -0.29%, p = 0.02). Multiple aspects of cerebral small vessel function on 7T-MRI were abnormal in CADASIL patients, indicative of increased arteriolar stiffness and regional abnormalities in reactivity, locally also in relation to white matter injury. These observations provide novel markers of cSVD for mechanistic and intervention studies. ANN NEUROL 2023;93:29-39.

Identifiants

pubmed: 36222455
doi: 10.1002/ana.26527
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-39

Subventions

Organisme : Medical Research Council
ID : MR/J006971/1
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol 2019;18:684-696.
Debette S, Schilling S, Duperron MG, et al. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol 2019;76:81-94.
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for researchinto small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.
van Norden AG, de Laat KF, van Dijk EJ, et al. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study. Biochim Biophys Acta 2012;1822:401-407.
Tuladhar AM, van Norden AG, de Laat KF, et al. White matter integrity in small vessel disease is related to cognition. NeuroImage Clin 2015;7:518-524.
Baykara E, Gesierich B, Adam R, et al. A novel imaging marker for small vessel disease based on Skeletonization of white matter tracts and diffusion histograms. Ann Neurol 2016;80:581-592.
Duering M, Konieczny MJ, Tiedt S, et al. Serum neurofilament light chain levels are related to small vessel disease burden. J Stroke 2018;20:228-238.
Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol 2009;8:643-653.
di Donato I, Bianchi S, De Stefano N, et al. Cerebral autosomal dominant Arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med 2017;15:1-12.
Hervé D, Chabriat H. CADASIL. J Geriatr Psychiatry Neurol 2010;23:269-276.
Joutel A, Monet-leprêtre M, Gosele C, et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 2010;120:433-445.
Dabertrand F, Krøigaard C, Bonev AD, et al. Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease. Proc Natl Acad Sci 2015;112:E796-E805.
Argirò A, Sciagrà R, Marchi A, et al. Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Eur J Neurol 2021;28:3809-3813.
Zwanenburg JJM, Van Osch MJP. Targeting cerebral small vessel disease with MRI. Stroke 2017;48:3175-3182.
van den Brink H, Kopczak A, Arts T, et al. Zooming in on cerebral small vessel function in small vessel diseases with 7T MRI: rationale and design of the “ZOOM@SVDs” study. Cereb Circ-Cogn Behav 2021;2:100013.
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.
Gesierich B, Tuladhar AM, ter Telgte A, et al. Alterations and test-retest reliability of functional connectivity network measures in cerebral small vessel disease. Hum Brain Mapp 2020;41:2629-2641.
Bouvy WH, Geurts LJ, Kuijf HJ, et al. Assessment of blood flow velocity and pulsatility in cerebral perforating arteries with 7-T quantitative flow MRI. NMR Biomed 2015;29:1295-1304.
Geurts L, Zwanenburg JJM, Klijn CJM, et al. Higher Pulsatility in cerebral perforating arteries in patients with small vessel disease related stroke, a 7T MRI study. Stroke 2019;50:62-68.
Arts T, Siero JCW, Biessels GJ, Zwanenburg JJM. Automated assessment of cerebral arterial perforator function on 7T MRI. J Magn Reson Imaging 2021;53:234-241.
Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 2017;96:17-42.
Uludaǧ K, Müller-Bierl B, Uǧurbil K. An integrative model for neuronal activity-induced signal changes for gradient and spin echo functional imaging. Neuroimage 2009;48:150-165.
Ainslie PN, Duffin J. Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement, and interpretation. Am J Physiol - Regul Integr Comp Physiol 2009;296:R1473-R1495.
Sleight E, Stringer MS, Marshall I, et al. Cerebrovascular reactivity measurement using magnetic resonance imaging: a systematic review. Front Physiol 2021;12:643468.
Thrippleton MJ, Shi Y, Blair G, et al. Cerebrovascular reactivity measurement in cerebral small vessel disease: rationale and reproducibility of a protocol for MRI acquisition and image processing. Int J Stroke 2018;13:195-206.
Sun C, Wu Y, Ling C, et al. Reduced blood flow velocity in lenticulostriate arteries of patients with CADASIL assessed by PC-MRA at 7T. J Neurol Neurosurg Psychiatry 2021;0:1-3.
Miao Q, Paloneva T, Tuisku S, et al. Arterioles of the lenticular nucleus in CADASIL. Stroke 2006;37:2242-2247.
Craggs LJL, Yamamoto Y, Deramecourt V, Kalaria RN. Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain. Brain Pathol 2014;24:495-509.
Arts T, Onkenhout LP, Amier RP, et al. Non-invasive assessment of damping of blood flow velocity Pulsatility in cerebral arteries with MRI. J Magn Reson Imaging 2022;55:1785-1794.
Rajani RM, Ratelade J, Domenga-Denier V, et al. Blood brain barrier leakage is not a consistent feature of white matter lesions in CADASIL. Acta Neuropathol Commun 2019;7:1-14.
Pettersen JA, Keith J, Gao F, et al. CADASIL accelerated by acute hypotension: arterial and venous contribution to leukoaraiosis. Neurology 2017;88:1077-1080.
Chabriat H, Pappata S, Ostergaard L, et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000;31:1904-1912.
Atwi S, Shao H, Crane DE, et al. BOLD-based cerebrovascular reactivity vascular transfer function isolates amplitude and timing responses to better characterize cerebral small vessel disease. NMR Biomed 2019;32:1-12.
Cheema I, Switzer AR, McCreary CR, et al. Functional magnetic resonance imaging responses in CADASIL. J Neurol Sci 2017;375:248-254.
Uludağ K, Blinder P. Linking brain vascular physiology to hemodynamic response in ultra-high field MRI. Neuroimage 2018;168:279-295.
Blair GW, Janssen E, Stringer MS, et al. Effects of Cilostazol and Isosorbide Mononitrate on cerebral hemodynamics in the LACI-1 randomized controlled trial. Stroke 2022;53:29-33.
Siero JCW, Bhogal A, Jansma JM. Blood oxygenation level-dependent/functional magnetic resonance imaging: underpinnings, practice, and perspectives. PET Clin 2013;8:329-344.
Geurts L, Biessels GJ, Luijten P, Zwanenburg J. Better and faster velocity pulsatility assessment in cerebral white matter perforating arteries with 7T quantitative flow MRI through improved slice profile, acquisition scheme, and postprocessing. Magn Reson Med 2018;79:1473-1482.

Auteurs

Hilde van den Brink (H)

Department of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Anna Kopczak (A)

Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Tine Arts (T)

Department of Radiology, Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands.

Laurien Onkenhout (L)

Department of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Jeroen C W Siero (JCW)

Department of Radiology, Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands.
Spinoza Centre for Neuroimaging Amsterdam, Amsterdam, The Netherlands.

Jaco J M Zwanenburg (JJM)

Department of Radiology, Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands.

Sandra Hein (S)

Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Mathias Hübner (M)

Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Benno Gesierich (B)

Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Medical Image Analysis Center (MIAC AG) and qbig, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.

Marco Duering (M)

Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Medical Image Analysis Center (MIAC AG) and qbig, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.

Michael S Stringer (MS)

Brain Research Imaging Centre, Centre for Clinical Brain Sciences, UK Dementia Research Institute Centre at the University of Edinburgh, Edinburgh, UK.

Jeroen Hendrikse (J)

Department of Radiology, Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands.

Joanna M Wardlaw (JM)

Brain Research Imaging Centre, Centre for Clinical Brain Sciences, UK Dementia Research Institute Centre at the University of Edinburgh, Edinburgh, UK.

Anne Joutel (A)

Institute of Psychiatry and Neurosciences of Paris, Université de Paris, Inserm U1266, Paris, France.

Martin Dichgans (M)

Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
German Center for Neurodegenerative Disease (DZNE), Munich, Germany.

Geert Jan Biessels (GJ)

Department of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH